Main menu button

Carlsquare advised SOMATEX in process of acquisition by group of entrepreneurs lead by WESTLAKE PARTNERS

A group of entrepreneurs lead by WESTLAKE PARTNERS in the form of E Med Solutions GmbH, Berlin, together with the founder of SOMATEX Medical Technologies GmbH, Teltow, acquired 100% of the shares of SOMATEX. The company was founded in 1992. In the coming years, the investment of an experienced and successful group of entrepreneurs is expected to make increased use of the multiple growth potentials of SOMATEX.

SOMATEX is a renowned expert for the development, manufacturing and distribution of high-class, disposable and minimally invasive instruments. The constantly growing product portfolio covers the fields of vertebroplasty (procedure to stabilise the vertebral body), biopsy, tumor ablation, tumor diagnostic and therapy, mammography and antenatal medicine. SOMATEX’ strength results from the company’s principle “permanent product innovation” and is based on the development of innovative specialized products and new solutions for the specific requirements of physicians. The company distributes the in-house developed products in more than 80 countries.

Client: SOMATEX Medical Technologies GmbH
Industry: Life Science and healthcare
Assignment: Sellside
de
SOMATEX Medical Technologies GmbH
de
Westlake Partners
Caspar Graf Stauffenberg
Caspar Graf Stauffenberg LinkedIn
Managing Partner